UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Capacitive response of PDMS-coated IDE platforms directly exposed to aqueous solutions containing volatile organic compounds

Sensors and actuators. B, Chemical, 2013, Vol.184, p.130-142

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie

European journal of cancer (1990), 2004-07, Vol.40 (10), p.1522-1529

2004

Link zum Volltext

Verfügbarkeit prüfen

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial

European journal of cancer (1990), 2021-11, Vol.157, p.268-277

2021

Link zum Volltext

Verfügbarkeit prüfen

Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006–2013

Environmental research, 2024-01, Vol.240, p.117417-117417, Article 117417

2024

Link zum Volltext

Verfügbarkeit prüfen

METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors

European journal of cancer (1990), 2024-02, Vol.198, p.113525-113525, Article 113525

2024

Link zum Volltext

Verfügbarkeit prüfen

Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial

European journal of cancer (1990), 2023-07, Vol.188, p.8-19

2023

Link zum Volltext

Verfügbarkeit prüfen

Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?

European journal of cancer (1990), 2024-05, Vol.202, p.114001-114001, Article 114001

2024

Link zum Volltext

Verfügbarkeit prüfen

Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival

European journal of cancer (1990), 2024-03, Vol.200, p.113583-113583, Article 113583

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis

European journal of cancer (1990), 2021-09, Vol.154, p.277-287

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

European journal of cancer (1990), 2020-12, Vol.141, p.82-91

2020

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous UPLC–MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: Minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2012-02, Vol.883-884 (3), p.161-171

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours

European journal of cancer (1990), 2016-07, Vol.62, p.9-17

2016

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study

European journal of cancer (1990), 2016-11, Vol.67, p.130-140

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study

European journal of cancer (1990), 2012-02, Vol.48 (3), p.289-296

2012

Link zum Volltext

Verfügbarkeit prüfen

Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: Clinic and radiologic characteristics and survival outcomes

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1939-1947

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

European journal of cancer (1990), 2011-01, Vol.47 (2), p.230-238

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours

European journal of cancer (1990), 2010-10, Vol.46 (15), p.2763-2770

2010

Link zum Volltext

Verfügbarkeit prüfen

Residing in urban areas with higher green space is associated with lower mortality risk: A census-based cohort study with ten years of follow-up

Environment international, 2021-03, Vol.148, p.106365, Article 106365

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychosocial impact of endometriosis: From co-morbidity to intervention

Best practice & research. Clinical obstetrics & gynaecology, 2018-07, Vol.50, p.2-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Spatial clustering of events on a network

Journal of transport geography, 2010-05, Vol.18 (3), p.411-418

2010

Link zum Volltext

Verfügbarkeit prüfen

Writing tremor: Should we look for a TOR1A mutation?

Journal of the neurological sciences, 2017-11, Vol.382, p.146-147

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(27)
Berichte
(1)

Sprache

Englisch
(28)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(25)
Humans
(21)
Oncology
(18)
Child
(15)
Child, Preschool
(14)
Female
(14)
Adolescent
(13)
Male
(12)
Tumors
(10)
Neoplasms - Drug Therapy
(9)
Biological And Medical Sciences
(8)
Hematology, Oncology And Palliative Medicine
(8)
Infant
(8)
Young Adult
(8)
Medical Sciences
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(6)
Children
(6)
Life Sciences
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(28)
Elsevier ScienceDirect Journals Complete
(28)
MEDLINE
(21)
IngentaConnect Journals
(8)
EZB Free E-Journals
(1)
Journals@Ovid Complete
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Capacitive response of PDMS-coated IDE platforms directly exposed to aqueous solutions containing volatile organic compounds

Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie

Phase II and biomarker study of programmed cell death protein 1 inhibitor nivolumab and metronomic cyclophosphamide in paediatric relapsed/refractory solid tumours: Arm G of AcSé-ESMART, a trial of the European Innovative Therapies for Children With Cancer Consortium

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial

Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006–2013

METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors

Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial

Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?

Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival

Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis

Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium

Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer

Simultaneous UPLC–MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: Minimization of matrix-effects, 2AG/1AG isomerization and degradation by toluene solvent extraction

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours

Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study

A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) study

Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: Clinic and radiologic characteristics and survival outcomes

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours

Residing in urban areas with higher green space is associated with lower mortality risk: A census-based cohort study with ten years of follow-up

Psychosocial impact of endometriosis: From co-morbidity to intervention

Spatial clustering of events on a network

Writing tremor: Should we look for a TOR1A mutation?

Aktive Filter

Suchergebnisse filtern